Clinical studies of tosufloxacin on chronic bacterial prostatitis

Clinical studies of tosufloxacin on chronic bacterial prostatitis

In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method. Nineteen patients who were evaluated by the UTI criteria we...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 7 vom: 01. Juli, Seite 673-8
1. Verfasser: Ikeuchi, T (VerfasserIn)
Weitere Verfasser: Kawamura, N, Suzuki, K, Onodera, S, Osada, T, Hirano, A, Satomi, Y, Yoshimura, S, Yamamoto, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1993
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Multicenter Study Anti-Infective Agents Fluoroquinolones Naphthyridines Tablets tosufloxacin GHJ553KQPS